To determine the role of Abi1 in p185Bcr-Abl-positive leukemia development, we set to completely deplete its expression in p185Bcr-Abl-positive leukemic cells using CRISPR/Cas9-mediated gene editing. The gene discussed is ABL1; the disease is leukemia.